当前位置:
X-MOL 学术
›
Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Prognostic Value of Low HER2 Expression on Treatment Outcomes in Metastatic Hormone Receptor-positive Breast Cancer Patients Treated with CDK4/6 Inhibitors and Endocrine Therapy
Clinical Oncology ( IF 3.4 ) Pub Date : 2024-03-07 , DOI: 10.1016/j.clon.2024.01.029 R. Muhammad , S. Mumtaz , N. Goyal , A. Konstantis
中文翻译:
HER2 低表达对接受 CDK4/6 抑制剂和内分泌治疗的转移性激素受体阳性乳腺癌患者的治疗结果的预后价值
更新日期:2024-03-07
Clinical Oncology ( IF 3.4 ) Pub Date : 2024-03-07 , DOI: 10.1016/j.clon.2024.01.029 R. Muhammad , S. Mumtaz , N. Goyal , A. Konstantis
中文翻译:
HER2 低表达对接受 CDK4/6 抑制剂和内分泌治疗的转移性激素受体阳性乳腺癌患者的治疗结果的预后价值